Clinical Trial Detail

NCT ID NCT03340558
Title Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer (ATELIER)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements no
Sponsors Niharika Mettu
Indications

colorectal cancer

Therapies

Atezolizumab

Atezolizumab + Cobimetinib

Age Groups: adult senior

No variant requirements are available.